牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer Amit Sachdev is set to sell 3,191 shares of common stock on 02/21/2024, as per the latest filing. The shares, valued at an aggregate market value of $1,345,868.07, were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Sachdev, who has sold a total of 7,476 shares in the past three months, amounting to gross proceeds of $3,144,053.94.
Vertex Pharmaceuticals Inc. officer Amit Sachdev is set to sell 3,191 shares of common stock on 02/21/2024, as per the latest filing. The shares, valued at an aggregate market value of $1,345,868.07, were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Sachdev, who has sold a total of 7,476 shares in the past three months, amounting to gross proceeds of $3,144,053.94.
最新文件顯示，Vertex Pharmicals Inc.高管阿米特·薩赫傑夫定於2024年2月21日出售3,191股普通股。這些股票的總市值爲1,345,868.07美元，於2024年2月20日作爲高性能股票收購，這是發行人的一種補償。該交易遵循了薩赫傑夫最近的銷售歷史，他在過去三個月中共出售了7,476股股票，總收益爲3,144,053.94美元。
最新文件顯示，Vertex Pharmicals Inc.高管阿米特·薩赫傑夫定於2024年2月21日出售3,191股普通股。這些股票的總市值爲1,345,868.07美元，於2024年2月20日作爲高性能股票收購，這是發行人的一種補償。該交易遵循了薩赫傑夫最近的銷售歷史，他在過去三個月中共出售了7,476股股票，總收益爲3,144,053.94美元。
有用
沒用